Cytori Press Releases http://ir.cytori.com/generated by Q4Tue, 24 Apr 2018 16:26:06 -0400Copyright Q4 Inc. All rights reserved.Enrollment Completed in ADRESU Clinical Trial of Cytori Cell Therapy™ for Stress Urinary Incontinencehttp://ir.cytori.com/investor-relations/news/news-details/2018/Enrollment-Completed-in-ADRESU-Clinical-Trial-of-Cytori-Cell-Therapy-for-Stress-Urinary-Incontinence/default.aspxWed, 28 Mar 2018 12:00:00 -0400Cytori Reports Fourth Quarter and Full Year 2017 Business and Financial Resultshttp://ir.cytori.com/investor-relations/news/news-details/2018/Cytori-Reports-Fourth-Quarter-and-Full-Year-2017-Business-and-Financial-Results/default.aspxThu, 08 Mar 2018 16:25:00 -0500Cytori to Webcast Fourth Quarter Financial Results on March 8thhttp://ir.cytori.com/investor-relations/news/news-details/2018/Cytori-to-Webcast-Fourth-Quarter-Financial-Results-on-March-8th/default.aspxThu, 22 Feb 2018 16:15:00 -0500Cytori Scleroderma Trial Data Presented at Systemic Sclerosis World Congresshttp://ir.cytori.com/investor-relations/news/news-details/2018/Cytori-Scleroderma-Trial-Data-Presented-at-Systemic-Sclerosis-World-Congress/default.aspxThu, 15 Feb 2018 08:00:00 -0500Cytori Therapeutics Announces Inducement Grants for New Employeeshttp://ir.cytori.com/investor-relations/news/news-details/2018/Cytori-Therapeutics-Announces-Inducement-Grants-for-New-Employees/default.aspxFri, 09 Feb 2018 16:45:00 -0500Enrollment Completed in Randomized Clinical Trial of Habeo™ Cell Therapy for Scleroderma and Impaired Hand Functionhttp://ir.cytori.com/investor-relations/news/news-details/2018/Enrollment-Completed-in-Randomized-Clinical-Trial-of-Habeo-Cell-Therapy-for-Scleroderma-and-Impaired-Hand-Function/default.aspxMon, 22 Jan 2018 09:00:00 -0500Cytori Closes Rights Offering for Gross Proceeds of $10 Millionhttp://ir.cytori.com/investor-relations/news/news-details/2017/Cytori-Closes-Rights-Offering-for-Gross-Proceeds-of-10-Million/default.aspxTue, 28 Nov 2017 16:05:00 -0500Cytori Announces Expiration of Oversubscribed Rights Offeringhttp://ir.cytori.com/investor-relations/news/news-details/2017/Cytori-Announces-Expiration-of-Oversubscribed-Rights-Offering/default.aspxFri, 24 Nov 2017 09:00:00 -0500Cytori Reports Reduction in Fibrosis Parameters in Scar Studyhttp://ir.cytori.com/investor-relations/news/news-details/2017/Cytori-Reports-Reduction-in-Fibrosis-Parameters-in-Scar-Study/default.aspxMon, 20 Nov 2017 09:00:00 -0500Cytori Reports Bioequivalence Trial Results in Ovarian Cancer at AAPShttp://ir.cytori.com/investor-relations/news/news-details/2017/Cytori-Reports-Bioequivalence-Trial-Results-in-Ovarian-Cancer-at-AAPS/default.aspxThu, 16 Nov 2017 08:00:00 -0500